RESEARCHER PROFILE
Professor Sant-Rayn Pasricha (Filmed April 2024)
Study lead and Acting WEHI Deputy Director
WEHI (Walter and Eliza Hall Institute of Medical Research)
Clinical Haematologist Royal Melbourne Hospital & Peter MacCallum Cancer Centre
Professor Sant-Rayn Pasricha is the Acting Deputy Director at the Walter Eliza Hall Institute of Medical Research in Melbourne, Australia. He is also a clinical haematologist at the Royal Melbourne Hospital and the Peter MacCallum Cancer Centre. From a young age, Prof Pasricha dreamed of becoming a doctor and found joy in learning about the human body and how to care for patients. After completing medical school, he developed a passion for working in low and middle-income countries, which led him to spend time working in East Timor, India, and Central Australia with First Nations communities.
Prof Pasricha went on to specialise in haematology, which covers a wide range of fields, including cancer biology, immunology, transplant, nutrition, pathology, and red cell blood transfusion. He completed his haematology training and earned a PhD in global health, which allowed him to explore his interests in public health, global health, and haematology. Prof Pasricha focused his research on the significant and common issue of anaemia, particularly in low-income countries. He conducted field studies in the villages of Karnataka, India, and spent five years working in the lab at the University of Oxford to understand iron biology.
Currently, Pasricha runs his own lab at WEHI, where he serves as a lab and division head, conducting anaemia research. His lab covers a range of basic science research areas, including exploratory biology on how red blood cells are made, iron biology, and the role of inflammation in anaemia. Additionally, his lab conducts global trials in Africa and South Asia to prevent and treat anaemia and nutritional disorders in children and pregnant women.
Prof Pasricha’s lab completed a large analysis on haemoglobin thresholds to define anaemia, which informed the new World Health Organization guidelines on anaemia. The lab also conducts large randomised controlled field studies on ways to treat anaemia in pregnancy and young babies in Malawi and Bangladesh.
Prof Pasricha is passionate about improving the health of people in low-income countries and finding innovative solutions to improve the health of mothers and children in particular. He focuses on anaemia, nutrition, and exposure to infectious diseases. Prof Pasricha is also deeply curious about how the body works and how different systems interact with each other and the outside environment.
As a clinician scientist, Pasricha finds his job both busy and fulfilling. He enjoys taking care of patients, keeping up with breakthroughs in medicine, and running a research program. Prof Pasricha spends a substantial amount of time thinking about his work and planning the next experiment or study. Outside of work, he enjoys spending time with his three children and being involved in the community.
You Might also like
-
Better biomarkers for predicting the incidence of having atherosclerosis and heart attack
Assoc Prof Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at The University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called chemokines.
-
CASE STUDY Link between levels of extracellular vesicles in the blood and tissue damage caused by diseases
A landmark study led by WEHI and La Trobe University has found a potential new diagnostic marker that could be used to better detect the level of tissue damage in our bodies.
This study revealed, for the first time, a link between levels of EVs in the blood and tissue damage caused by diseases such as leukaemia.
Researchers hope to leverage the critical new insight to develop a blood test to monitor cancer patients with tissue damage, which could, in future, enhance treatment strategies for blood cancers and other diseases.
-
Cancer survivorship and exercise oncology
Professor Sandra Hayes is the Director of Research at Cancer Council Queensland (CCQ), where she leads a comprehensive cancer research program encompassing cancer epidemiology, prevention, detection, treatment, and survivorship.
With a BAppSci (Hons) and a PhD in exercise oncology, Professor Hayes’s expertise lies in quantifying the impact of cancer diagnosis and treatment on physical and psychosocial wellbeing, quality of life, and survival. She also evaluates innovative supportive care strategies, particularly exercise, to improve post-cancer lives.